Sanofi (EPA:SAN) has been given a €72.00 ($88.89) price objective by Jefferies Group in a research note issued on Friday. The brokerage presently has a “neutral” rating on the stock. Jefferies Group’s price objective would indicate a potential upside of 8.81% from the company’s previous close.
Other equities analysts also recently issued reports about the stock. Sanford C. Bernstein set a €82.00 ($101.23) target price on shares of Sanofi and gave the stock a “neutral” rating in a research note on Wednesday, February 7th. Berenberg Bank set a €81.00 ($100.00) target price on shares of Sanofi and gave the stock a “neutral” rating in a research note on Wednesday, February 14th. Goldman Sachs set a €74.00 ($91.36) target price on shares of Sanofi and gave the stock a “neutral” rating in a research note on Tuesday, March 13th. Kepler Capital Markets set a €83.00 ($102.47) target price on shares of Sanofi and gave the stock a “buy” rating in a research note on Tuesday, February 6th. Finally, Deutsche Bank set a €93.00 ($114.81) target price on shares of Sanofi and gave the stock a “buy” rating in a research note on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of €79.41 ($98.04).
Shares of EPA:SAN opened at €66.17 ($81.69) on Friday. Sanofi has a 12 month low of €63.09 ($77.89) and a 12 month high of €92.97 ($114.78).
COPYRIGHT VIOLATION WARNING: “Jefferies Group Analysts Give Sanofi (SAN) a €72.00 Price Target” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3353529/jefferies-group-analysts-give-sanofi-san-a-72-00-price-target.html.
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.